Uncategorized

Three notable updates on COVID-19 for ASC leaders to know:

On Oct. 12, Johnson & Johnson temporarily paused its COVID-19 vaccine candidate clinical trials after a participant developed an unexplained illness.

While largely isolated from initial and subsequent COVID-19 responses, ASCs have to ensure they have a comprehensive infection prevention plan to reduce the risk of viral transmission and continue elective procedures.

Researchers at Australia's national science agency, CSIRO, found evidence that the virus that causes COVID-19 can survive on common surfaces for up to 28 days, according to Technology Networks.

Here's what six otolaryngoloists told Becker's ASC Review about their outlook on the field over the next one to two years:

A woman lost hearing in one ear after having a mild COVID-19 infection, according to an Oct. 12 CNN report.

A woman lost hearing in one ear after having a mild COVID-19 infection, according to an Oct. 12 CNN report.

Otolaryngology is a growing field that's faced unique challenges amid the COVID-19 pandemic. Six otolaryngologists told Becker's ASC Review about what keeps them up at night.

Tarrytown, N.Y.-based ENT and Allergy Associates announced that a new otolaryngologist will join its office in the Bay Ridge neighborhood of Brooklyn next year, according to an Oct. 7 press release.

Here are eight hospitals and health systems that opened or announced plans for ASCs in September: